Mayo Clinic’s Post

Radioligand therapy (RLT) is an innovative type of nuclear medicine that targets markers on tumor cells and/or their microenvironment to deliver the treatment mostly to the affected tumor cells, while limiting unwanted effects on surrounding healthy cells. ↪️The scientific innovation in radioligand therapies is progressing rapidly. Yet, the healthcare system readiness for this treatment modality is lagging. This chart shows the framework for RLT capacity and measurement. Download the report to learn about the key priorities for RLT readiness: https://bit.ly/47v5tEW #HealthcareInnovation #CancerCare

Join Us for the Launch of the Radioligand Therapy (RLT) #Policy #Recommendations. We are excited to invite you to a unique gathering that brings together experts in #nuclear medicine to discuss the future of #Radioligand Therapy (RLT) for #cancer care. This event aims to address the #barriers to RLT adoption in #Europe and provide actionable #policy recommendations to ensure proper patient access to this innovative #treatment. 🗓 Date: 16 July 🕒 Time: 14:00 - 16:00 (followed by a cocktail reception) 📍Location: Irish College Leuven University’s Auditorium, Belgium 🔗 Register Here: RLT Policy Recommendations Launch Event https://lnkd.in/d5_aAQw2 Don’t miss this #opportunity to be at the forefront of advancements in #cancer care. Join us in promoting cutting-edge expertise in nuclear medicine and #RLT. #NuclearMedicine #RadioligandTherapy #CancerCare #PolicyRecommendations #HealthcareInnovation #RLTAcademy #MedicalExperts #PatientAccess #EuropeanHealthcare #InnovativeTreatments

Right on Krishneel (Ak.science) ! Nuclear medicine uses #radiopharmaceuticals to #diagnose and treat various diseases, such as cancer, heart disease, and infections. It differs from other imaging methods because it shows the body's functions and metabolism, not just its structure. It can detect problems that other forms may miss." Subscribe to our monthly newsletter http://eepurl.com/gno7pn and stay updated with our activities. See all about us on our LinkTree: https://lnkd.in/d7h6xCtG #LiquidFission #GotThorium #Fission4All #RadiationIsGood4U https://lnkd.in/eDccPitv

📰 BLOG: Perhaps, what ORAU is most known for during our early years is our Medical Division. In the 24 years of operation, the Medical Division of ORAU advanced nuclear medicine and cancer treatment in seven tangible ways. This list includes the highlights from a couple dozen years of research and practice. Read more below 🔽 🔽 🔽 https://bit.ly/3xhJTqV #FurtherTogether

“I can show them that is where the cancer is hiding and that is where the medication went and will deliver its radiation” - Dr Geoffrey Johnson, MD PhD. Dr Geoffrey Johnson has succinctly explained what nuclear medicine/radiopharmaceutical can do for cancer treatment which I truly believe to be the next frontier for cancer treatment. Besides imaging the tumour, nuclear imaging allows also the tracking of where the medication (radiopharmaceutical) goes - that allows us to predict whether the medication will have the intended on-target effect or off-target side effects. This brings precision to medicine in a whole other level - one that the drug-target relationship can be observed visually. Please watch this space! https://lnkd.in/gWyHduNf

📢A new PET imaging agent shows promise in identifying medullary thyroid cancer according to research published in The Journal of Nuclear Medicine. Learn more➡️https://lnkd.in/eb5vSiQY #molecularimaging #nuclearmedicine #petct #theranostics

ASP Isotopes' stable isotopes play a crucial role in the production of radioisotopes, which are pivotal in modern nuclear medicine. These radioisotopes are used in a wide range of diagnostic and therapeutic procedures, including cardiological conditions, cancer, neurological disorders etc. The opportunity ahead is enormous, and currently, there are severe shortages of all medical isotopes. #NASDAQ: $ASPI #isotopes #radioisotopes #medicine #nuclearmedicine

Let's talk about Cancer! Share your thoughts, questions or stories about cancer with the #AskAtulaya. Your questions will be answered by our Head of Nuclear Medicine, Dr. Ravinder Sidhu Together, let's Close the Care Gap. #AtulayaHealthcare #CareForCancer #CancerAwareness

📰 NEW BLOG: Perhaps, what ORAU is most known for during our early years is our Medical Division. In the 24 years of operation, the Medical Division of ORAU advanced nuclear medicine and cancer treatment in seven tangible ways. This list includes the highlights from a couple dozen years of research and practice. Check it out below 🔽 🔽 🔽 https://bit.ly/3xhJTqV #FurtherTogether

#𝗡𝘂𝗰𝗹𝗲𝗮𝗿 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲/𝗥𝗮𝗱𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗼𝗻 𝗮 𝗚𝗿𝗼𝘄𝘁𝗵 𝗧𝗿𝗮𝗷𝗲𝗰𝘁𝗼𝗿𝘆! In 2023, the Nuclear Medicine/Radiopharmaceuticals market was valued at US $6.04 Bn, and it's expected to soar to US $11.05 Bn by 2030, growing at a robust CAGR of 9%! 📈 𝗟𝗲𝘁'𝘀 𝗵𝗮𝗿𝗻𝗲𝘀𝘀 𝘁𝗵𝗲 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝗻𝘂𝗰𝗹𝗲𝗮𝗿 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝘁𝗼 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲!https://lnkd.in/gyk72f_N 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗮𝗻𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗣𝗼𝘄𝗲𝗿: Crucial for diagnosing and treating diseases that conventional medicine struggles with. 𝗦𝗣𝗘𝗖𝗧 𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗪𝗮𝘆: Expected to register the highest growth due to its extensive use in diagnosing cancer, cardiovascular, thyroid, and neurological disorders. 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗚𝗿𝗼𝘄𝘁𝗵: North America leads the charge, followed by Europe and APAC, thanks to advanced healthcare infrastructure and growing awareness of radiopharmaceutical benefits. Despite high equipment costs, the increasing incidence of cancer and cardiac ailments continues to drive market growth. #NuclearMedicine #Radiopharmaceuticals #HealthcareInnovation #MarketGrowth #MedicalImaging #Therapeutics #HealthcareIndustry #FutureOfMedicine